Literature DB >> 18398593

AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia.

Florian Herse1, Anne Cathrine Staff, Lydia Hering, Dominik N Müller, Friedrich C Luft, Ralf Dechend.   

Abstract

Pre-eclampsia is a common, pregnancy-induced disorder, consisting of hypertension and proteinuria. The condition is one of the leading causes for maternal and perinatal morbidity and mortality. Nonetheless, the underlying molecular mechanisms remain unclear. Immunological mechanisms and the renin-angiotensin system have been implicated in the development of pre-eclampsia. Agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) have been identified in pre-eclamptic patients, unifying the two hypothesis. Evidence has also accumulated for the existence and importance of a local, utroplacental renin-angiotensin system. We summarize recent data emphasizing the pathophysiological role for the autoantibodies and the uteroplacental renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398593     DOI: 10.1007/s00109-008-0332-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  44 in total

Review 1.  The immunology of preeclampsia.

Authors:  G A Dekker; B M Sibai
Journal:  Semin Perinatol       Date:  1999-02       Impact factor: 3.300

2.  Trophoblast and the endometrium--a workshop report.

Authors:  R Pijnenborg; J D Aplin; R Ain; E Bevilacqua; J N Bulmer; J Cartwright; B Hüppertz; M Knöfler; C Maxwell; L Vercruysse
Journal:  Placenta       Date:  2004-04       Impact factor: 3.481

3.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

4.  Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith.

Authors:  Keiichi Kamijo; Kazuyuki Ishikawa; Megumi Tanaka
Journal:  Endocr J       Date:  2005-10       Impact factor: 2.349

5.  Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.

Authors:  Carl A Hubel; Gerd Wallukat; Myles Wolf; Florian Herse; Augustine Rajakumar; James M Roberts; Nina Markovic; Ravi Thadhani; Friedrich C Luft; Ralf Dechend
Journal:  Hypertension       Date:  2007-01-08       Impact factor: 10.190

6.  Angiotensinogen T235 expression is elevated in decidual spiral arteries.

Authors:  T Morgan; C Craven; L Nelson; J M Lalouel; K Ward
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

7.  Preeclampsia -- a state of sympathetic overactivity.

Authors:  H P Schobel; T Fischer; K Heuszer; H Geiger; R E Schmieder
Journal:  N Engl J Med       Date:  1996-11-14       Impact factor: 91.245

8.  Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature.

Authors:  Thomas Walther; Gerd Wallukat; Alexander Jank; Sabine Bartel; Heinz-Peter Schultheiss; Renaldo Faber; Holger Stepan
Journal:  Hypertension       Date:  2005-10-31       Impact factor: 10.190

9.  Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.

Authors:  Cissy Chenyi Zhou; Shakil Ahmad; TieJuan Mi; Lingwei Xia; Shahrzad Abbasi; Peter W Hewett; ChunXiao Sun; Asif Ahmed; Rodney E Kellems; Yang Xia
Journal:  Circ Res       Date:  2006-12-07       Impact factor: 17.367

10.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

View more
  25 in total

1.  Identification of the primary outcomes that result from deficient spiral arterial modification in pregnant mice.

Authors:  B Anne Croy; Suzanne D Burke; Valerie F Barrette; Jianhong Zhang; Kota Hatta; Graeme N Smith; Juares Bianco; Aureo T Yamada; Michael A Adams
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

2.  Recent insights into the pathophysiology of preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Expert Rev Obstet Gynecol       Date:  2010-09-01

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 4.  Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface.

Authors:  M J Soares; D Chakraborty; M A Karim Rumi; T Konno; S J Renaud
Journal:  Placenta       Date:  2012-01-28       Impact factor: 3.481

Review 5.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

Review 6.  A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.

Authors:  Sandra M Blois; Ralf Dechend; Gabriela Barrientos; Anne Cathrine Staff
Journal:  Cell Mol Life Sci       Date:  2014-09-06       Impact factor: 9.261

7.  Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats.

Authors:  Katrin Wenzel; Augustine Rajakumar; Hannelore Haase; Nele Geusens; Norbert Hubner; Herbert Schulz; Justin Brewer; Lyndsay Roberts; Carl A Hubel; Florian Herse; Lydia Hering; Fatimunnisa Qadri; Carsten Lindschau; Gerd Wallukat; Robert Pijnenborg; Harald Heidecke; Gabriela Riemekasten; Friedrich C Luft; Dominik N Muller; Babette Lamarca; Ralf Dechend
Journal:  Hypertension       Date:  2011-05-16       Impact factor: 10.190

8.  Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis.

Authors:  Victor M Pulgar; Liliya M Yamaleyeva; Jasmina Varagic; Carolynne M McGee; Michael Bader; Ralf Dechend; Allyn C Howlett; K Bridget Brosnihan
Journal:  Hypertension       Date:  2014-06-16       Impact factor: 10.190

Review 9.  Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology.

Authors:  A C Palei; F T Spradley; J P Warrington; E M George; J P Granger
Journal:  Acta Physiol (Oxf)       Date:  2013-05-07       Impact factor: 6.311

Review 10.  Potential markers of preeclampsia--a review.

Authors:  Simon Grill; Corinne Rusterholz; Rosanna Zanetti-Dällenbach; Sevgi Tercanli; Wolfgang Holzgreve; Sinuhe Hahn; Olav Lapaire
Journal:  Reprod Biol Endocrinol       Date:  2009-07-14       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.